Besides, RFA induced systemic immune variation in innate immune cells (including natural killer (NK) cells and plasmacytoid DCs) and adaptive immune cells (including tumor-specific T cells, antigen-presenting cells [APCs] and CD8 central memory T cells) (60–62). This evidence concerns the gene CD8A and neoplasm.